Ceprotin Treatment Registry

Trial Profile

Ceprotin Treatment Registry

Phase of Trial: Phase III

Latest Information Update: 19 Jan 2018

At a glance

  • Drugs Protein C (Primary) ; Protein C
  • Indications Protein C deficiency
  • Focus Adverse reactions; Registrational
  • Sponsors Baxalta; Baxter Healthcare Corporation
  • Most Recent Events

    • 10 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Dec 2014 Planned primary completion date changed from 1 Jul 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record
    • 12 Dec 2014 Planned End Date changed from 1 Sep 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top